Titan Company Limited (TITAN)
Investor Presentation
Investor Presentation - June 2026
- Titan aims 2.0x revenue and EBIT growth by FY30 for Domestic Business; CaratLane targets 2.3x revenue and 2.5x EBIT growth
- Jewellery division targets doubling revenue and ~11% market share by FY30 with ~1,400 stores
- EyeCare division plans 2.2x revenue and 2.5x EBIT growth by FY30, focusing on clinical-led premium omni-channel
- International Business aims 2.5x revenue and 5.5x EBIT growth by FY30, led by Tanishq, Mia, and Damas
- Watches division targets 2.1x revenue and 2.2x EBIT growth by FY30 with premium retail expansion
- Damas franchise targets 2.0x growth by CY29 with focus on GCC market expansion and brand repositioning
- FY26 highlights: ₹76,078 Cr revenue, ₹8,082 Cr EBIT; strong growth in Jewellery and Emerging Businesses
- Strategic focus on innovation, premiumization, omni-channel, and international expansion
- Risks include gold price volatility, geopolitical tensions, regulatory changes, and supply chain disruptions
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 TITAN — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add TITAN to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Titan Company Limited
Important.
The summary above is generated automatically from Titan Company Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.